$10.88
Today
as of Aug 5, 16:52 ET
Last 30 days
Recent Press Releases & News
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
Overview
52-week range
$8.67
$197
1% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+1.2%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-5.89 | — | — | -2,577% | +1.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.23 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $-0.33 | — | — | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.22 | — | — | — | +1.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.35 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.31 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.31 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.45 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.58 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-5M | $-7M | $-5M | — | $-6M | $-5M |
| Net income | $-4M | — | $-5M | $-7M | $-5M | — | $-6M | $-5M |
| EPS (diluted) | $-5.89 | — | $-0.23 | $-0.33 | $-7.75 | — | $-0.35 | $-0.31 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3M | $3M | $2M | $2M | $3M | $2M | $18M | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $25M | $29M | $31M | $36M | $39M | $44M | $49M | $40M |
| Total assets | $26M | $30M | $32M | $37M | $41M | $45M | $50M | $41M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $2M | $3M | $4M | $2M | $3M | $3M | $3M |
| Total equity | $24M | $27M | $29M | $33M | $38M | $42M | $47M | $38M |
Implied volatility — last 90 days
No IV snapshots yet for NVNO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.